Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients

Published:2017-03-27 Issue:6 Volume:19 Page:809-813
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Al Jobori Hussein¹,Daniele Giuseppe¹,Adams John¹,Cersosimo Eugenio¹,Triplitt Curtis¹,DeFronzo Ralph A.¹,Abdul-Ghani Muhammad¹^ORCID

Affiliation:

1. Diabetes Division; University of Texas Health Science Center; San Antonio Texas

Funder

Boehringer-Ingelheim

South Texas Veterans Health Care System

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12881/fullpdf

Reference16 articles.

1. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes;Abdul-Ghani;Endocr Rev,2011

2. SGLT2 inhibitors in the management of type 2 diabetes;Monica Reddy;Endocrine,2016

3. Euglycemic diabetic ketoacidosis;Modi;Curr Diabetes Rev,2016

4. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition;Peters;Diabetes Care,2015

5. Diabetic ketoacidosis with canagliflozin, a sodium-glucose cotransporter 2 inhibitor, in patients with type 1 diabetes;Peters;Diabetes Care,2016

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial;Diabetes, Obesity and Metabolism;2024-05-03

2. Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation;Metabolism;2024-05

3. The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice;Cardiovascular Diabetology;2024-02-29

4. The therapeutic potential of ketones in cardiometabolic disease: impact on heart and skeletal muscle;American Journal of Physiology-Cell Physiology;2024-02-01

5. SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus;Current Medicinal Chemistry;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3